Review: in type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

Ann Intern Med. 2015 Jan 20;162(2):JC6. doi: 10.7326/ACPJC-2015-162-2-006.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin, Long-Acting / therapeutic use*
  • Receptors, Glucagon / agonists*

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Receptors, Glucagon